Beyond the mega-trial: certainty and uncertainty
Open Access
- 1 October 1992
- Vol. 68 (10) , 352-355
- https://doi.org/10.1136/hrt.68.10.352
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.BMJ, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- Group sequential methods for clinical trials allowing early acceptance of Ho and incorporating costsBiometrika, 1982
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974
- Streptokinase in Recent Myocardial Infarction: A Controlled Multicentre TrialBMJ, 1971
- EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTIONThe Lancet, 1965